Cellectis S.A. (ADR)
General ticker "CLLS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $206.3M (TTM average)
Cellectis S.A. (ADR) follows the US Stock Market performance with the rate: 48.7%.
Estimated limits based on current volatility of 4.5%: low 4.46$, high 4.88$
Factors to consider:
- Total employees count: 116 as of 2015
- Current price 78.3% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.18$, 2.71$]
- 2025-12-31 to 2026-12-31 estimated range: [1.15$, 2.63$]
Financial Metrics affecting the CLLS estimates:
- Positive: with PPE of -1.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: Operating cash flow per share per price, % of 15.12 > 13.24
- Negative: negative Industry operating cash flow (median)
- Positive: 18.93 < Shareholder equity ratio, % of 34.16 <= 41.86
Short-term CLLS quotes
Long-term CLLS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $19.17MM | $0.76MM | $41.51MM |
| Operating Expenses | $108.84MM | $98.06MM | $101.06MM |
| Operating Income | $-89.67MM | $-97.30MM | $-59.55MM |
| Non-Operating Income | $-8.94MM | $-19.16MM | $22.79MM |
| Interest Expense | $3.79MM | $5.31MM | $7.45MM |
| R&D Expense | $97.50MM | $87.65MM | $90.54MM |
| Income(Loss) | $-98.60MM | $-116.46MM | $-36.76MM |
| Taxes | $-0.09MM | $-0.37MM | $0.00MM |
| Profit(Loss)* | $-106.14MM | $-101.06MM | $-36.83MM |
| Stockholders Equity | $117.97MM | $84.69MM | $131.03MM |
| Assets | $261.22MM | $334.27MM | $383.54MM |
| Operating Cash Flow | $-87.44MM | $-24.75MM | $22.10MM |
| Capital expenditure | $2.44MM | $1.07MM | $2.58MM |
| Investing Cash Flow | $-2.76MM | $-15.51MM | $-102.63MM |
| Financing Cash Flow | $1.15MM | $82.86MM | $89.80MM |
| Earnings Per Share** | $-2.33 | $-1.77 | $-0.41 |
| Ordinary share to ADR | 2.00x | 2.00x | 2.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.